The Global Drug Device Combination Market size is expected to grow at an annual average of 5.3% during 2021-2027. A drug-device combination product is a medical device consisting of a device and active pharmaceutical ingredients that are physically or chemically bonded together as a “single entity”. These products lead to safe and effective management and treatment of many disorders due to accurate drug delivery, topical administration and individualized treatment. Major drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. These technologically advanced products are used to manage and treat many chronic diseases such as cancer, diabetes, respiratory problems, cardiovascular disease, wound healing, and more.
(Get 15% Discount on Buying this Report)
A full report of Global Drug Device Combination Market is available at: https://www.orionmarketreports.com/drug-device-combination-market/47725/
The following players are covered in this report:
By Product
- Drug-eluting stent
- Infusion pump
- Photodynamic therapy
- Antimicrobial wound dressing
- Prefilled syringe
By Wound Type
- Cardiovascular disease
- Diabetes
- Respiratory problem
- Cancer treatment
- Antimicrobial application
- Other applications
By End User
- Hospital & clinic
- Ambulatory surgery center (ASC)
- Home care setting
- Other end users
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
